BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31392723)

  • 21. Hydrogen sulfide and hepatic lipid metabolism - a critical pairing for liver health.
    Loiselle JJ; Yang G; Wu L
    Br J Pharmacol; 2020 Feb; 177(4):757-768. PubMed ID: 30499137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H
    Citi V; Martelli A; Brancaleone V; Brogi S; Gojon G; Montanaro R; Morales G; Testai L; Calderone V
    Br J Pharmacol; 2020 Nov; 177(21):4931-4941. PubMed ID: 32783196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.
    Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
    Umansky V; Blattner C; Gebhardt C; Utikal J
    Cancer Immunol Immunother; 2017 Aug; 66(8):1015-1023. PubMed ID: 28382399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of T cells by myeloid-derived suppressor cells in cancer.
    Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
    Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the gasotransmitter hydrogen sulfide in pathological calcification.
    Castelblanco M; Nasi S; Pasch A; So A; Busso N
    Br J Pharmacol; 2020 Feb; 177(4):778-792. PubMed ID: 31231793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Lim HX; Choi S; Cho D; Kim TS
    Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.
    Van Wigcheren GF; De Haas N; Mulder TA; Horrevorts SK; Bloemendal M; Hins-Debree S; Mao Y; Kiessling R; van Herpen CML; Flórez-Grau G; Hato SV; De Vries IJM
    Oncoimmunology; 2021; 10(1):1935557. PubMed ID: 34239773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.
    Suk Lee Y; Davila E; Zhang T; Milmoe HP; Vogel SN; Bromberg JS; Scalea JR
    Innate Immun; 2019 Jan; 25(1):46-59. PubMed ID: 30782043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
    Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
    Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
    Wu K; Tan MY; Jiang JT; Mu XY; Wang JR; Zhou WJ; Wang X; Li MQ; He YY; Liu ZH
    Clin Immunol; 2018 Aug; 193():60-69. PubMed ID: 29410331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti-PD-1 resistance.
    Ajith A; Mamouni K; Horuzsko DD; Musa A; Dzutsev AK; Fang JR; Chadli A; Zhu X; Lebedyeva I; Trinchieri G; Horuzsko A
    J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37651197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal.
    Baumann T; Dunkel A; Schmid C; Schmitt S; Hiltensperger M; Lohr K; Laketa V; Donakonda S; Ahting U; Lorenz-Depiereux B; Heil JE; Schredelseker J; Simeoni L; Fecher C; Körber N; Bauer T; Hüser N; Hartmann D; Laschinger M; Eyerich K; Eyerich S; Anton M; Streeter M; Wang T; Schraven B; Spiegel D; Assaad F; Misgeld T; Zischka H; Murray PJ; Heine A; Heikenwälder M; Korn T; Dawid C; Hofmann T; Knolle PA; Höchst B
    Nat Immunol; 2020 May; 21(5):555-566. PubMed ID: 32327756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycyrrhizic acid facilitates anti-tumor immunity by attenuating Tregs and MDSCs: An immunotherapeutic approach.
    Juin SK; Ghosh S; Majumdar S
    Int Immunopharmacol; 2020 Nov; 88():106932. PubMed ID: 32890791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-derived itaconate suppresses cytotoxic CD8
    Zhao H; Teng D; Yang L; Xu X; Chen J; Jiang T; Feng AY; Zhang Y; Frederick DT; Gu L; Cai L; Asara JM; Pasca di Magliano M; Boland GM; Flaherty KT; Swanson KD; Liu D; Rabinowitz JD; Zheng B
    Nat Metab; 2022 Dec; 4(12):1660-1673. PubMed ID: 36376563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Anti-melanoma Efficacy of a Pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells.
    Liu J; Hu Y; Guo Q; Yu X; Shao L; Zhang C
    Front Immunol; 2019; 10():2721. PubMed ID: 31849942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
    Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
    Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.